InsidersTradesSigma
Follow the HYPHENS PHARMA INTERNATIONAL LIMITED share price and the full management transaction log of the company, a listed equity based in Singapore. Shares trade on SG SG, under the authority of SGX. Market capitalisation: €106.6m. The latest transaction was disclosed on 17 June 2026 (Other). Among the most active insiders: HYPHENS PHARMA INTERNATIONAL LIMITED. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
HYPHENS PHARMA INTERNATIONAL LIMITED is a company active in the pharmaceutical sector, specializing in the distribution of healthcare products. It is listed on the Singapore Exchange Securities Trading Limited (XSES).